Exposed: Moderna’s Vaccine Against Vaccine Dissent
This story originally was published by Real Clear Wire
By Lee Fang
Real Clear Wire
Finances at the vaccine manufacturer Moderna began to fall almost as quickly as they had risen, as most Americans resisted getting yet another COVID booster shot. The pharmaceutical company, whose pioneering mRNA vaccine had turned it from small startup to biotech giant worth more than $100 billion in just a few years, reported a third-quarter loss last year of $3.6 billion, as most Americans refused to get another COVID booster shot.
In a September call aimed at shoring up investors, Moderna’s then–chief commercial officer, Arpa Garay, attributed some of the hesitancy pummeling Moderna’s numbers to uninformed vaccine skeptics.
